PTGX Operating Cash Flow (Statement)
Protagonist Therapeutics Inc · Operating Cash Flow (Statement)
PTGX Operating Cash Flow (Statement)
Latest reported$219.05Mperiod ending
PTGX Quarterly Cash from Operations (-$2.43M → $219.05M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
PTGX operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 219,052,000 | |
| -48,943,000 | |
| -36,975,000 | |
| -1,937,000 | |
| -28,780,000 | |
| 125,363,000 | |
| -29,178,000 | |
| -27,863,000 | |
| 268,622,000 | |
| -27,429,000 | |
| 16,960,000 | |
| -26,611,000 | |
| -26,238,000 | |
| -34,347,000 | |
| -31,635,000 | |
| -25,201,000 | |
| -13,635,000 | |
| -37,666,000 | |
| -26,939,000 | |
| -28,470,000 | |
| -23,700,000 | |
| -28,756,000 | |
| -18,867,000 | |
| -16,287,000 | |
| -21,482,000 | |
| -15,848,000 | |
| -14,289,000 | |
| -14,246,000 | |
| 3,670,000 | |
| -16,662,000 | |
| -10,135,000 | |
| -9,276,000 | |
| -15,398,000 | |
| -15,138,000 | |
| -14,149,000 | |
| 40,704,000 | |
| -12,327,000 | |
| -10,356,000 | |
| -9,680,000 | |
| -6,980,000 | |
| -8,073,000 | |
| -5,239,000 | |
| -4,739,000 | |
| -3,769,000 | |
| -3,444,000 | |
| -2,433,000 |